July 07, 2026 10:36 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough
AstraZeneca vaccine
Image Credit: AstraZeneca Twitter Handle

UK to offer AstraZeneca vaccine's alternative to people below 30 yrs over concerns of blood clots

| @indiablooms | Apr 08, 2021, at 04:27 am

London/IBNS: Amidst concerns over rare blood clot disorders resulting in deaths of people following inoculation, a government committee in the UK has said that those below 30 years of age should be offered an alternative to the AstraZeneca Covid vaccine.

While 19 people have died in the UK from rare blood clots after receiving the jab, about 79 such cases have been reported in the country.

"Adults who are aged 18 to 29 years old who do not have an underlying health condition... should be offered an alternative Covid-19 vaccine in preference to the AstraZeneca vaccine, where such an alternative vaccine is available," Wei Shen Lim of the Joint Committee on Vaccination and Immunisation, said at a press conference.

The AstraZeneca vaccine is being manufactured by India's Pune-based Serum Institute in collaboration with Oxford University under the name of "Covishield".

It is one of the two vaccines approved by India's drug regulator for emergency use in January this year.

The World Health Organization (WHO) is also expected to update its safety assessment on the AstraZeneca vaccine soon, informed an official on Tuesday.

Initially, UK had not linked the blood clot disorder with the vaccine's jabs but changed its stance as increasing cases were reported.

European Union's drug regulator had said it had found a "possible link" between the AstraZeneca vaccine and the clotting disorder.

Earlier in March, several European countries like Denmark, Norway, Austria, Netherlands and Iceland had temporarily suspended the use of Oxford-AstraZeneca's Covid-19 vaccine over concerns about patients suffering from post-jab blood clots.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.